Trial Profile

First in Human Phase 1 Study of AOH1996 in Patients With Refractory Solid Tumors

Status: Recruiting

Phase of Trial: Phase I

Latest Information Update: 11 Jun 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs AOH-1996 (Primary)
Indications Liver cancer; Liver metastases; Pancreatic cancer; Solid tumours
Focus Adverse reactions; First in man
Sponsors City of Hope National Medical Center

Most Recent Events

30 Apr 2025 Results evaluating safety and efficacy of AOH-1996 presented at the 116th Annual Meeting of the American Association for Cancer Research.
26 Oct 2022 New trial record
19 Oct 2022 According to a City of Hope National Medical Center media release, this study is open at City of Hope Los Angeles.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com